A diagnostic scale for Alzheimer’s disease based on cerebrospinal fluid biomarker profiles-Reference-Cited by-同舟云学术

A diagnostic scale for Alzheimer’s disease based on cerebrospinal fluid biomarker profiles

Published:2014 Issue:3 Volume:6 Page:38
ISSN:1758-9193
Container-title:Alzheimer's Research & Therapy
language:en
Short-container-title:Alzheimers Res Ther

Author:

Lehmann Sylvain,Dumurgier Julien,Schraen Susanna,Wallon David,Blanc Frédéric,Magnin Eloi,Bombois Stéphanie,Bousiges Olivier,Campion Dominique,Cretin Benjamin,Delaby Constance,Hannequin Didier,Jung Barbara,Hugon Jacques,Laplanche Jean-Louis,Miguet-Alfonsi Carole,Peoc’h Katell,Philippi Nathalie,Quillard-Muraine Muriel,Sablonnière Bernard,Touchon Jacques,Vercruysse Olivier,Paquet Claire,Pasquier Florence,Gabelle Audrey

Publisher

Springer Science and Business Media LLC

Subject

Cognitive Neuroscience,Neurology (clinical),Neurology

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The free plasma amyloid Aβ1–42/Aβ1–40 ratio predicts conversion to dementia for subjects with mild cognitive impairment with performance equivalent to that of the total plasma Aβ1–42/Aβ1–40 ratio. The BALTAZAR study;Neurobiology of Disease;2024-04

2. Perfusion Imaging and Inflammation Biomarkers Provide Complementary Information in Alzheimer’s Disease;Journal of Alzheimer's Disease;2023-11-21

3. Phenotype and imaging features associated with APP duplications;Alzheimer's Research & Therapy;2023-05-11

4. Interest of eye movement study in early diagnosis of posterior cortical atrophy: A case-report;Revue Neurologique;2023-03

5. The Early Diagnosis of Alzheimer’s Disease: A Patient-Centred Conversation with the Care Team;Neurology and Therapy;2022-12-18